Breaking News
September 26, 2018 - Horwitz Prize Awarded for Work on Hormones
September 26, 2018 - Genomic ‘islands’ evolved from viruses can be converted into ‘anti-bacterial drones’
September 26, 2018 - Most running injuries may be influenced by simple technique errors, finds study
September 26, 2018 - Optimizing dopaminergic treatment improves non-motor symptoms and quality of life
September 26, 2018 - NIRS-IVUS imaging identifies patients and plaques vulnerable to subsequent adverse cardiac events
September 26, 2018 - New insights into what drives organ transplant rejection
September 26, 2018 - Tiny Device Is a ‘Huge Advance’ for Treatment of Severe Heart Failure
September 26, 2018 - Research shows possibility to postpone cumbersome treatment for low-risk MDS patients
September 26, 2018 - CSU chemists may help in making extracorporeal life support devices more effective
September 26, 2018 - Brain marker linked with aggression in toddlers identified
September 26, 2018 - Blood-brain barrier can be important biomarker for early diagnosis of Alzheimer’s disease
September 26, 2018 - PCORI, AHRQ announce awards to support patient-centered outcomes research in learning health systems
September 26, 2018 - Scientists discover and characterize human skeletal stem cells
September 26, 2018 - Repeat CT Common in Peds Traumatic Epidural Hematoma
September 26, 2018 - Genetics Home Reference: bunion
September 26, 2018 - Increase observed in hearts from drug-intoxicated donors
September 26, 2018 - For Heart Failure Patients, Mitral Valve Procedure Improved Outcomes
September 26, 2018 - TINY cancer detection device shows promise as point-of-care detector of KSHV
September 26, 2018 - Women with non-small cell lung cancers live longer than their male counterparts
September 26, 2018 - KTU researchers engineer experimental bone to help treat osteoarthritis patients
September 26, 2018 - Foundation for a Smoke-Free World calls for proposals to implement Smoke-Free Index
September 26, 2018 - Functional Imagery Training helps lose five times more weight than talking therapy
September 26, 2018 - Fewer American Teens Having Sex, Most Using Birth Control
September 26, 2018 - We are predisposed to forgive, new research suggests
September 26, 2018 - Insomnia Exacts Heavy Toll on Quality of Life
September 26, 2018 - Clinical study shows efficacy, safety of novel drug-eluting stent with improved radiographic visibility
September 26, 2018 - Cytox, AIBL announce expanded agreement to assess genetic risk for Alzheimer’s
September 26, 2018 - Study finds persistent rate of lawnmower injury-related emergency department visits
September 26, 2018 - Researchers find molecule that halts, reverts neurodegeneration caused by Parkinson’s disease
September 26, 2018 - Novartis announces winners of 2018 eXcellence in Ophthalmology Vision Award
September 26, 2018 - New spinout company to tackle drug-resistant infections with novel antibiotics
September 26, 2018 - In depression the brain region for stress control is larger
September 26, 2018 - Smuggling RNA into cells can activate the immune system to fight cancer
September 26, 2018 - Special Focus Issue takes wide view of complementary and integrative medicine in cancer
September 26, 2018 - Researchers now confirm that genome duplication drives evolution of species
September 25, 2018 - Study provides evidence of beta lactamase producing, antimicrobial resistant E. coli in U.S. retail meat
September 25, 2018 - UCI study finds new cause of cerebral microbleeds
September 25, 2018 - Researchers propose mechanism by which ASTN2 protein defects lead to brain disorders
September 25, 2018 - Chinese and German researchers to cooperate more closely in future for better food
September 25, 2018 - Recent study helps predict probability of pregnant mothers to have child with autism
September 25, 2018 - New online, sound matching tool offers tinnitus sufferers potential treatment options
September 25, 2018 - UC Davis researchers take critical step in developing more effective Salmonella vaccine
September 25, 2018 - Antibiotics best paediatric treatment for children’s chronic wet cough
September 25, 2018 - Looking beyond opioids: Stanford pain psychologist briefs Congress
September 25, 2018 - Organs actively fighting back against autoimmune diseases, finds study
September 25, 2018 - Lancaster professor aims to understand how genes affect smoking cessation
September 25, 2018 - Human-oriented perspective needed to better understand Parkinson’s disease
September 25, 2018 - Physical activity may have beneficial effects for people with rare Alzheimer’s disease
September 25, 2018 - FDA Updates on Valsartan Recalls
September 25, 2018 - 3-D-printed tracheal splints used in groundbreaking pediatric surgery
September 25, 2018 - Who is the designated driver, or proxy, for your health decisions?
September 25, 2018 - New chemo-optogenetic method enables multi-directional activity control of cellular processes
September 25, 2018 - Study explores link between genetic predisposition to Alzheimer’s and cardiometabolic risk factors
September 25, 2018 - NeoTract presents new clinical data from studies of UroLift System for patients with BPH
September 25, 2018 - Patients with paralysis manage to walk thanks to new technology
September 25, 2018 - Statins Improve Long-Term Survival After AAA Repair
September 25, 2018 - Novel brain network linked to chronic pain in Parkinson’s disease
September 25, 2018 - Researchers reassess negative pressure wound therapy as its benefit and harm remain unclear
September 25, 2018 - Older adults with ‘fall plan of care’ less likely to suffer fall-related hospitalizations
September 25, 2018 - FDA lifts partial clinical hold that paused enrollment of new patients in tazemetosta clinical trials
September 25, 2018 - IME Medical Electrospinning establishes state-of-the-art manufacturing lab facilities
September 25, 2018 - Phase 1 and 2 clinical trials of entrectinib drug in ROS1-positive NSCLC show promising results
September 25, 2018 - How to Protect Your Eyesight
September 25, 2018 - Novel approach allows researchers to define how cells in the retina respond to diabetes
September 25, 2018 - Columbia University announces winners of 2018 Louisa Gross Horwitz Prize
September 25, 2018 - New model enables anyone to run powerful simulations, complex calculations easily
September 25, 2018 - Clinical trial investigators found non-compliant with requirement to report results on EU register
September 25, 2018 - Study analyzes quality of protein supplements in function of source, treatment and storage
September 25, 2018 - FDA grants Orphan Drug Designation to Myelo001 for treatment of Acute Radiation Syndrome
September 25, 2018 - U.S. Alzheimer’s Cases to Nearly Triple by 2060
September 25, 2018 - Improving cell replacement therapy for Parkinson’s disease
September 25, 2018 - Genervon reports new findings that drug candidate GM6 attenuates Alzheimer’s disease in mice model
September 25, 2018 - FDA approves new 5 mm diameter drug-eluting stent from Cook Medical
September 25, 2018 - New $17.8 million grant ensures USC at forefront of research on tobacco-related health risks
September 25, 2018 - Researchers analyze response to combination immunotherapy for patients with rare skin cancer
September 25, 2018 - Study sheds light on how brain protein may be involved neurodevelopmental disorders
September 25, 2018 - Where to draw the line on incentives
September 25, 2018 - Solid fuel use linked with increased risk of hospitalization or death from respiratory diseases
September 25, 2018 - ‘Trouble Brewing’ report highlights steps that governments can take to reduce alcohol-related harms
September 25, 2018 - Recurrence risk of VTE appears similar for patients with cancer and those with unprovoked VTE
SCHILLER introduces latest generation of ECG device, CARDIOVIT AT-102 G2

SCHILLER introduces latest generation of ECG device, CARDIOVIT AT-102 G2

image_pdfDownload PDFimage_print

With the launch of CARDIOVIT AT-102 G2, SCHILLER is releasing the latest generation of ECG devices.

SCHILLER’s latest ECG device CARDIOVIT AT-102 G2 has been launched. The developers set new standards in electrocardiography with state-of-the-art high-end features, user-friendly design and proven SCHILLER quality for hospitals, clinics and medical practices. Image rights: SCHILLER AG, Photographer Christian Grau

Dr. Michela Perrini, Global Product Manager at SCHILLER in Baar, Switzerland:

In the CARDIOVIT AT-102 G2 we have implemented our many years of experience, customer wishes and optimization possibilities. Our developers have used the latest and best technologies. The device makes a quantum leap in electrocardiography in one fell swoop.”

The first 300 units CARDIOVIT AT-102 G2 have already been shipped. The decision makers of Mehiläinen in Finland reveal the devices key qualities they wanted to adopt in their nationwide institution.

The Swiss medical engineering company SCHILLER launches the latest generation in electrocardiography for hospitals, clinics and medical practices. CARDIOVIT AT-102 G2 features state-of-the-art technology, extremely high operation speed, ease of use, and bi-directional WiFi communication to implement the patient data and send the ECG. The CARDIOVIT AT-102 G2 is equipped with an 8-inch HD color display for quick and effective ECG review. The screen has touch function keys, which, together with the navigation keys, allow a very fast device operation.

Simplifying the daily clinic life

The sophisticated hardware and software make CARDIOVIT AT-102 G2 very fast. The device’s internal memory can accommodate several hundred ECGs. If a record is to be transmitted to an EPA / HIS/ PACS system by WiFi, this can be done in less than a second. This task is what appreciates one of the first customers that bought five units of CARDIOVIT AT-102 G2: Mehiläinen, a nationwide provider of healthcare services in Finland. Kristina Hotakainen, Director of laboratory services at Mehiläinen Oy:

Finnish national recommendations are going to DICOM ECG. So we are updating our ecg process as well as archiving systems. Our long, good and reliable cooperation and experience with SCHILLER systems and devices gave faith in continuity.”

CARDIOVIT AT-102 G2 will be connected with the Mehiläinen Carestream PACS system through the new SCHILLER SEMA. “The automated DICOM workflow is easy and needs a minimum of manual entries”, says Mehiläinen IT Service Engineer Matti Pekka Räsänen. Fast reliable connectivity in the new workflow with minimum manual work in data recording was an important feature for the Mehiläinen decision makers. Paperless fast recording is easy and effective for the Mehiläinen laboratories and occupational nurses.

High speed for greatest efficiency

“In particular, the very fast and very simple operation was a main customer requirement. With CARDIOVIT AT-102 G2, we were able to bring today’s state of the art into medical technology – not an easy task, but we succeeded,” says Dr. Michela Perrini, Global Product Manager at SCHILLER. Using only one navigation key and in three short steps it is possible to download the patient data via PDQ or work list, to record the ECG, and then to save, print and transmit the data.

The device supports paperless workflows, which saves costs. When a paper report is needed, custom printouts can be made from the internal full sized (A4), high-resolution thermal printer. The long battery life makes a single battery charge sufficient for eight hours of ECG recordings during the labor-intensive clinical routine. In addition, CARDIOVIT AT-102 G2 is robust and reliable. The alphanumeric keyboard is sealed and easy to clean, making it easier to comply with the strict hospital hygiene requirements. The trolley’s smoothly running wheels and a handle at the optimum height allows comfortable moving and working. With the standardly mounted storage basket, all important accessories are always at hand.

Proven SCHILLER quality

With its latest innovation, SCHILLER has developed an impressive ECG device with many new features that far exceed the high requirements in the healthcare sector. The body illustration on the large screen shows the exact electrode placement for different configurations. A new function indicates when electrodes have been connected incorrectly. CARDIOVIT AT-102 G2 has highest signal quality, which is especially important for paediatric ECGs. The automatic interpretation provides a reliable analysis of the ECG for both children and adults. Three software options complete CARDIOVIT AT-102 G2: Stress ECG, ETM Sport for the automatic interpretation of the athlete’s heart and CCAA (Culprit Coronary Artery Algorithm).

From a one-man operation to the world’s leading ECG supplier

Company founder Alfred Schiller started his company with ECG devices in the 1970s. To date, a variety of device types have been developed. SCHILLER is one of the world’s leading developers and suppliers of cardiac diagnostics. Currently, more than a dozen ECG devices are available, with special features depending on customer needs, location or the desired accessories. CARDIOVIT AT-102 G2 is the latest electrocardiography product. It is CE approved. The CARDIOVIT AT-102 G2 is produced at the SCHILLER headquarters in Baar, Switzerland.

Tagged with:

About author